NextBillion - An Initiative of the William Davidson Institute at the University of Michigan

Tuesday, April 1, 2014

British pharmaceutical giant GlaxoSmithKline on Monday announced a five-year investment programme for sub-Saharan Africa to fuel the company’s growth and to serve an area with “pressing health needs”.

“The company is currently reviewing possible locations in countries including Rwanda, Ghana and Ethiopia and the selected sites will be announced in due course and subject to government agreement,” it said.